|
Topics in Magnetic Resonance Imaging
Online Submission and Review System
SCOPE |
|
ETHICAL/LEGAL CONSIDERATIONS
A submitted manuscript must be an original contribution not previously
published (except as an abstract or a preliminary report), must not be under
consideration for publication elsewhere, and, if accepted, must not be published
elsewhere in similar form, in any language, without the consent of Lippincott
Williams & Wilkins. Each person listed as an author is expected to have
participated in the study to a significant extent. Although the editors
and referees make every effort to ensure the validity of published manuscripts,
the final responsibility rests with the authors, not with the Journal, its
editors, or the publisher. All manuscripts must be submitted on-line through
the journal's Web site at https://tmri.edmgr.com/. See submission instructions
under "On-line manuscript submission."
Patient Anonymity and Informed Consent
It is the author's responsibility to ensure that a patient's anonymity
be carefully protected and to verify that any experimental investigation
with human subjects reported in the manuscript was performed with informed
consent and following all the guidelines for experimental investigation
with human subjects required by the institution(s) with which all the authors
are affiliated. Authors should mask patients' eyes and remove patients'
names from figures unless they obtain written consent from the patients
and submit written consent with the manuscript.
Copyright
All authors must sign a copy of the Journal's "Authorship
Responsibility, Financial Disclosure, and Copyright Transfer" form
and submit it at the time of manuscript submission.
Compliance with NIH and Other Research Funding Agency Accessibility Requirements
A number of research funding agencies now require or request authors to submit the post-print (the article after peer review and acceptance but not the final published article) to a repository that is accessible online by all without charge. As a service to our authors, LWW will identify to the National Library of Medicine (NLM) articles that require deposit and will transmit the post-print of an article based on research funded in whole or in part by the National Institutes of Health, Wellcome Trust, Howard Hughes Medical Institute, or other funding agencies to PubMed Central. The revised Copyright Transfer Agreement provides the mechanism.
Permissions
Authors must submit written permission from the copyright owner
(usually the publisher) to use direct quotations, tables, or illustrations
that have appeared in copyrighted form elsewhere, along with complete details
about the source. Any permissions fees that might be required by the copyright
owner are the responsibility of the authors requesting use of the borrowed
material, not the responsibility of Lippincott Williams & Wilkins.
MANUSCRIPT SUBMISSION
Each issue has a guest editor. A submitted manuscript must be an
original contribution not previously published (except as an abstract or
preliminary report), must not be under consideration for publication elsewhere,
and, must not be published elsewhere in similar form, in any language, without
the consent of Lippincott Williams & Wilkins. Each person listed as
an author is expected to have participated in the study to a significant
extent. Although the editors and referees make every effort to ensure the
validity of published manuscripts, the final responsibility rests with the
authors, not with the Journal, its editors, or the publisher.
On-line Manuscript Submission
All manuscripts must be submitted on-line through the new Web site
at https://tmri.edmgr.com/. First-time users: Please click
the Register button from the main menu and enter the requested information.
On successful registration, you will be sent an e-mail indicating your user
name and password. Print a copy of this information for future reference.
Note: If you have received an e-mail from us with an assigned user
ID and password, or if you are a repeat user, do not register again. Just
log in. Once you have an assigned ID and password, you do not have to re-register,
even if your status changes (that is, author, reviewer, or editor). Authors:
Please click the log-in button from the menu at the top of the page and
log in to the system as an Author. Submit your manuscript according to the
author instructions. You will be able to track the progress of your manuscript
through the system. If you experience any problems, please contact Julie
Chase [email: jchase@lww.com, phone: 215-521-8329, fax: 215-521-8488]. Requests
for help and other questions will be addressed in the order received.
PREPARATION OF MANUSCRIPT
Manuscripts that do not adhere to the following instructions will
be returned to the corresponding author for technical revision before undergoing
peer review.
Title Page
Title page must be submitted as a separate file.
Include on the title page (a) complete manuscript title; (b) authors' full
names, highest academic degrees, and affiliations; (c) name and address
for correspondence, including fax number, telephone number, and e-mail address;
(d) address for reprints if different from that of corresponding author;
and (e) all sources of support, including pharmaceutical and industry support,
that require acknowledgment.
The title page must also include disclosure of funding received for this work from any of the following organizations: National Institutes of Health (NIH);
Wellcome Trust; Howard Hughes Medical Institute (HHMI); and other(s).
Structured Abstract and Key Words
Abstract must be submitted as a separate file. Limit the abstract
to 250 words. Do not cite references in the abstract. Limit the use of abbreviations
and acronyms. Use the following subheads: Objectives, Methods, Results,
and Conclusions. List three to five key words.
Text
Organize the manuscript into four main headings: Introduction,
Materials and Methods, Results, and Discussion. Define abbreviations at
first mention in text and in each table and figure. If a brand name is cited,
supply the manufacturer's name and address (city and state/country). Acknowledge
all forms of support, including pharmaceutical and industry support, in
an Acknowledgments paragraph.
Abbreviations
For a list of standard abbreviations, consult the American Medical
Association Manual of Style, 9th edition (available from the American Medical
Association, 515 N. State Street, Chicago, IL 60610) or other standard sources.or
other standard sources. Write out the full term for each abbreviation at
its first use unless it is a standard unit of measure.
References
The authors are responsible for the accuracy of the references.
Key the references (double-spaced) at the end of the manuscript. Cite the
references in text in the order of appearance. Cite unpublished data—such
as papers submitted but not yet accepted for publication and personal communications,
including e-mail communications—in parentheses in the text. If there
are more than three authors, name only the first three authors and then
use et al. Refer to the List of Journals Indexed in Index Medicus
for abbreviations of journal names, or access the list at http://www.nlm.nih.gov/tsd/serials/lji.html.
Sample references are given below
Journal Article [follow AMA style, but use et al. after the first 3
authors]
1. Rand NS, Dawson JM, Juliao SF, et al. In vivo macrophage
recruitment by murine intervertebral disc cells. J Spinal Disord. 2001;14:339-342.
Book Chapter
2. Todd VR. Visual information analysis: frame of reference
for visual perception. In: Kramer P, Hinojosa J, eds. Frames of Reference
for Pediatric Occupational Therapy. Philadelphia, PA: Lippincott Williams
& Wilkins; 1999:205-256.
Entire Book
3. Kellman RM, Marentette LJ. Atlas of Craniomaxillofacial
Fixation. Philadelphia, PA: Lippincott Williams & Wilkins; 1999.
Software
4. Epi Info [computer program]. Version 6. Atlanta,
GA: Centers for Disease Control and Prevention; 1994.
Online Journals
5. Friedman SA. Preeclampsia: a review of the role of prostaglandins.
Obstet Gynecol [serial online]. January 1988;71:22-37. Available from: BRS
Information Technologies, McLean, VA. Accessed December 15, 1990.
Database
6. CANCERNET-PDQ [database online]. Bethesda, MD: National
Cancer Institute; 1996. Updated March 29, 1996.
World Wide Web
7. Gostin LO. Drug use and HIV/AIDS [JAMA HIV/AIDS
Web site]. June 1, 1996. Available at: http://www.ama-assn.org/special/hiv/ethics.
Accessed June 26, 1997.
Figures
Art should be created/scanned and saved and submitted as either
a TIFF (tagged image file format), an EPS (encapsulated PostScript) file,
or a PPT (PowerPoint) file. Line art must have a resolution of at least
1200 dpi (dots per inch), and electronic photographs—radiographs,
CT scans, and so on—and scanned images must have a resolution of at
least 300 dpi. If fonts are used in the artwork, they must be converted
to paths or outlines or they must be embedded in the files. Color images
must be created/scanned and saved and submitted as CMYK files. Please note
that artwork generated from office suite programs such as CorelDRAW and
MS Word and artwork downloaded from the Internet (JPEG or GIF files) cannot
be used. Cite figures consecutively on the site, and number them in the
order in which they are discussed. All electronic art that cannot be successfully
uploaded must be submitted on a 3½-inch high-density disk, a CD-ROM,
or an Iomega Zip disk, accompanied by high-resolution laser prints of each
image.
Figure Legends
Include legends for all figures. They should be brief and specific,
and they should appear on a separate manuscript page after the references.
Use scale markers in the image for electron micrographs, and indicate the
type of stain used.
Color Figures
The journal accepts for publication color figures that will enhance
an article. Authors who submit color figures will receive an estimate of
the cost for color reproduction. If they decide not to pay for color reproduction,
they can request that the figures be converted to black and white at no
charge.
Tables
Create tables using the table creating and editing feature of your
word processing software (eg, Word, WordPerfect). Do not use Excel or comparable
spreadsheet programs. Group all tables in a separate file. Cite tables consecutively
in the text, and number them in that order. Each table should appear on
a separate sheet and should include the table title, appropriate column
heads, and explanatory legends (including definitions of any abbreviations
used). Do not embed tables within the body of the manuscript. They should
be self-explanatory and should supplement, rather than duplicate, the material
in the text. Style
Pattern manuscript style after the American Medical Association Manual
of Style (9th edition). Stedman's Medical Dictionary (27th
edition) and Merriam Webster's Collegiate Dictionary (10th edition)
should be used as standard references. Refer to drugs and therapeutic agents
by their accepted generic or chemical names, and do not abbreviate them.
Use code numbers only when a generic name is not yet available. In that
case, supply the chemical name and a figure giving the chemical structure
of the drug is required. Copyright or trade names of drugs should be capitalized
and placed in parentheses after the name of the drug. Names and locations
(city and state in USA; city and country outside USA) of manufacturers of
drugs, supplies, or equipment cited in a manuscript are required to comply
with trademark law and should be provided in parentheses. Units of measure
should be expressed in the metric system, and temperatures should be expressed
in degrees Celsius. Conventional units should be written as SI units as
appropriate.
AFTER ACCEPTANCE Page Proofs and Corrections
Corresponding authors will receive electronic page proofs to check
the copyedited and typeset article before publication. Portable document
format (PDF) files of the typeset pages and support documents (eg, reprint
order form) will be sent to the corresponding author by e-mail. Complete
instructions will be provided with the e-mail for downloading and printing
the files and for faxing the corrected page proofs to the publisher. Those
authors without an e-mail address will receive traditional page proofs.
It is the author's responsibility to ensure that there are no errors in
the proofs. Changes that have been made to conform to journal style will
stand if they do not alter the authors' meaning. Only the most critical
changes to the accuracy of the content will be made. Changes that are stylistic
or are a reworking of previously accepted material will be disallowed. The
publisher reserves the right to deny any changes that do not affect the
accuracy of the content. Authors may be charged for alterations to the proofs
beyond those required to correct errors or to answer queries. Proofs must
be checked carefully and corrections faxed within 24 to 48 hours of receipt,
as requested in the cover letter accompanying the page proofs.
Reprints
Authors will receive a reprint order form and a price list with
the page proofs. Reprint requests should be faxed to the publisher with
the corrected proofs, if possible. Reprints are normally shipped 6 to 8
weeks after publication of the issue in which the item appears. Contact
the Reprint Department, Lippincott Williams & Wilkins, 530 Walnut Street,
Philadelphia, PA 19106 with any questions.
Publisher's Contact
Fax corrected page proofs, reprint order form, and any other related
materials to Journal Production Editor, Topics in Magnetic Resonance
Imaging, 215-521-8483 or 215-521-8485. Color proofs should be returned
to Journal Production Editor, Topics in Magnetic Resonance Imaging,
Lippincott Williams & Wilkins, 530 Walnut Street, Philadelphia, PA 19106.
